WHO Meeting to Develop H5N1 Influenza Pandemic Vaccine
Initiative for Vaccine Research (IVR) I8-MTG-0210 Immunization, Vaccines and Biologicals (IVB) World Health Organization 20, AVENUE APPIA – CH-1211 GENEVA 27 – SWITZERLAND – TEL CENTRAL +41 22 791 2111 – FAX CENTRAL +41 22 791 3111 – WWW.WHO.INT TECHNICAL CONSULTATION ON MATERNAL INFLUENZA IMMUNIZATION EVIDENCE AND IMPLEMENTATION 25-26 MARCH 2015 SALLE D, WHO HQ, GENEVA, SWITZERLAND List of Participants Participants Alex Adjagba, SIVAC Initiative, AMP, France Bruna Alves de Rezende, SIVAC Initiative, AMP, France Azucena Bardaji, Barcelona Institute for Global Health (ISGlobal), Hospital Clinic, University of Barcelona, Spain Niranjan Bhat, PATH, Seattle, USA Zulfiqar Bhutta, (Co-chair) Centre for Global Child Health, Toronto, Canada Jan Bonhoeffer, Brighton Collaboration, Basel, Switzerland Joseph Bresee, US Centers for Disease Control and Prevention, Atlanta, USA Marta Coelho Nunes, Respiratory and Meningeal Pathogens Research Unit, Chris Hani-Baragwanath Hospital, Bertsham, Gauteng, South Africa Gaston De Serres, Institut National de Santé Publique du Québec, Québec, Canada Deshayne Fell, Born Ontario, Ottawa, Canada Jessica Fleming, PATH, Seattle, USA Brad Gessner, Agence de Médecine Préventive, Paris, France David Green, Public Health England, Centre for Infections, London, UK Sam Halabi, The O’Neill Institute for National and Global Health Law at Georgetown University, Washington DC, USA Alan Hinman, Taskforce for Global Health, Atlanta, USA Jane Hirst, Nuffield Department of Obstetrics & Gynaecology, University of Oxford, UK Angela
[Show full text]